Novartis Investigative Site
Santiago 15705
0 studies enrolling now · 2 studies all time
What they study most
Neoplasms, Breast
Studies at this site
ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D
— Completed
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
— APPROVED_FOR_MARKETING